← Oncology Approval Tracker

FDA DECISION ·

Bendamustine Hydrochloride Injection (Apotex)

bendamustine hydrochloride · Apotex

FDA approvalNew formulationChronic lymphocytic leukemia and indolent B-cell lymphoma
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

A separately approved bendamustine injection for adults with CLL or indolent B-cell NHL progressing during or within six months after rituximab-containing therapy.

LAMPGEN ANALYSIS

Why it matters

The injection application adds a specific product presentation alongside other FDA bendamustine actions.

What research teams should watch

Verify concentration, preparation and infusion instructions and document prior rituximab timing for the lymphoma population.

PRIMARY RECORDS

Sources